Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001104659-25-002584
Filing Date
2025-01-10
Accepted
2025-01-10 16:46:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRER14A tm252001-2_prer14a.htm PRER14A 902724
2 GRAPHIC lg_cyclacel-4clr.jpg GRAPHIC 17219
3 GRAPHIC sg_jeffreywbullock-bw.jpg GRAPHIC 10632
4 GRAPHIC lg_secretarysoffistamp-bwlr.jpg GRAPHIC 13622
5 GRAPHIC px_cyclacel25pg01-4c.jpg GRAPHIC 309035
6 GRAPHIC px_cyclacel25pg02-4c.jpg GRAPHIC 169554
  Complete submission text file 0001104659-25-002584.txt   1585280
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-50626 | Film No.: 25523610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)